In animal models of NAFLD and metabolic syndrome, Cr supplementation downregulated the expression of sterol regulatory element-binding protein-1 (SREBP-1) mRNA, which is a key transcription factors involved in the synthesis of cholesterol and fatty acids (28, 33, 37). Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.